Benzinga - by Lisa Levin, Benzinga Editor.
The Nasdaq 100 closed higher by 0.5% on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.
McCormick & Company
- The Trade: McCormick & Company, Incorporated (NYSE: MKC) Vice President, Gen Counsel Jeffery Schwartz sold a total of 2,000 shares at an average price of $64.37. The insider received around $128,738 from selling those shares.
- What’s Happening: McCormick reported downbeat third-quarter sales results.
- What McCormick & Company Does: In its more-than 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings.
CME Group
- The Trade: CME Group Inc. (NASDAQ: CME) Sr MD Global Head Equity & FX Timothy Francis McCourt sold a total of 1,043 shares at an average price of $216.37. The insider received around $225,674 from selling those shares.
- What’s Happening: CME Group reported better-than-expected earnings for the third quarter.
- What CME Group Does: Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities.
- The Trade: Moderna, Inc. (NASDAQ: MRNA) Director Noubar B. Afeyan sold a total of 10,000 shares at an average price of $76.99. The insider received around $769,854 from selling those shares.
- What’s Happening: Moderna and CEPI disclosed a strategic partnership that will harness mRNA platform to accelerate the development of vaccines against viral disease outbreaks.
- What Moderna Does: Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018.
- The Trade: Airbnb, Inc. (NASDAQ: ABNB) Director, Chief Strategy Officer Nathan Blecharczyk sold a total of 26,077 shares at an average price of $119.56. The insider received around $3.12 million from selling those shares.
- What’s Happening: Seaport Global recently initiated coverage on Airbnb with a Neutral rating.
- What Airbnb Does: Started in 2008, Airbnb is the world's largest online alternative accommodation travel agency, also offering booking services for boutique hotels and experiences.
Check This Out: McDonald's, HSBC Holdings And 3 Stocks To Watch Heading Into Monday
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.